STEPHANIE METZGER: Open Payments
NPI 1609420942 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$540 in 19 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $502 · 2025 $540
Food & beverage: $540
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 2 | $157 |
| Calliditas Therapeutics US Inc. | 2 | $52 |
| Ardelyx, Inc. | 2 | $39 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| Corcept Therapeutics | 1 | $33 |
| LEO Pharma Inc. | 1 | $30 |
| AstraZeneca Pharmaceuticals LP | 1 | $27 |
| SCPHARMACEUTICALS INC. | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Veloxis Pharmaceuticals, Inc. | 1 | $24 |
Products named: Filspari, TARPEYO, IBSRELA, JARDIANCE, Korlym, ANZUPGO, FARXIGA, FUROSCIX.
Industry payments across WA — which companies pay providers there.
